Pharma IQ Members

Market Access

Find out everything you need to know about the latest pricing, reimbursement and market access strategies that will drive your business development.

235 results
of 22
Contributor: Pharma IQ News
Posted: Mon, 03/05/2018
money pharma
As groundbreaking oncology therapies hand patients new hopes, a whitepaper has urged the industry to treat and prevent the financial burdens that plague cancer patients Full Content »
Contributor: Ernan Roman
Posted: Tue, 02/13/2018
Ernan Roman explores recent research showing that pharma and biotech companies make expensive mistakes by neglecting the power and necessity of customer experience strategies. Full Content »
Contributor: Pharma IQ News
Posted: Tue, 02/13/2018
world risk
Pharma businesses operating on an international scale will have to negotiate fragile climates in 2018 Full Content »
Contributor: James Wright
Posted: Tue, 02/06/2018
Money Pharma value pricing
Delving into the common misconceptions surrounding value based pricing and value based payment in pharma. Full Content »
Contributor: Chanice Henry
Posted: Tue, 01/16/2018
pills thumb
The market share of generics in Portugal reached a new record recently, according to provisional figures from Infarmed. Full Content »
Contributor: Chanice Henry
Posted: Fri, 01/05/2018
Money pharmaceutical
A new national price list for medical services went live on the first of January Full Content »
Contributor: Pharma IQ
Posted: Wed, 01/03/2018
Calendars thumb
Download this calendar to view the editorial focus for Pharma and Pharma Logistics IQ for 2018. Full Content »
Contributor: Catalyst Corporate Finance
Posted: Tue, 12/05/2017
Despite concern expressed by the pharmaceutical industry, Catalyst Corporate Finance argues that the UK’s decision to leave the European Union in fact represents a major opportunity for the country’s dynamic and world-leading pharmaceutical sector. Full Content »
Contributor: David B. Sudzus
Posted: Tue, 12/05/2017
David B. Sudzus
David B. Sudzus and Russell J. Chibe explore possible outcomes of the Blue Ribbon Commission Report and the Declaration of National Health Emergency regarding the U.S’s Opioid Crisis. Full Content »
Contributor: Joyce El Hokayem
Posted: Tue, 11/21/2017
lab plant
Human Genetics Scientist, Joyce El Hokayem examines the benefits phytomedicine could offer to today’s healthcare systems and the challenges researchers in this market face Full Content »
Contributor: Pharma IQ News
Posted: Tue, 10/31/2017
Pharma IQ looks at the potential of artificial intelligence in drug discovery. Full Content »
235 results
of 22